fbpx

Male, 35 y/o

Patient internal ID: 302683160

ICD-10 code

C16.2 Malignant Neoplasm of the Stomach Body.

Diagnosis (incl metastases/stage) and year

June 2020
Adenocarcinoma of Gastric Body cT3N1Mo G3 (ypT3N3a LV1 R0).

Previous treatment

Chemotherapy (FLOT4), Surgery (Gastrectomy) + HIPEC, Chemotherapy (Cisplatin + Fluorouracil).

Prognosis and survival expectation

The prognosis remains poor, with a median survival of ~40 months from diagnosis.

Treatment provided

Autologous DCV (7 doses) and CIK (9 doses) over a period of 6 months.

Patient survival/condition and year

Patient survived 21 months from diagnosis, he had reached a stable disease control, however, he died due to other medical complications. It can be concluded that Immunotherapy, alongside Chemotherapy, Surgery and HIPEC Chemotherapy, benefited for disease control.

Date of Review

15/10/2023